Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China

Life Science

Safe-Haven Sentiment Heats Up, Digital Gold Luster Fades

Cryptocurrency, Technology

It’s Time to Allocate Commodities: Three ETFs Worth Watching

Mining, Precious Metals

Amazon Dethrones Walmart in Revenue, Does Walmart’s Investment Value Remain?

Consumer Goods

Are Tech Stocks Still Worth Buying? These Two Long-Term Picks May Be Worth Watching

Technology

Tesla’s Robotaxi Business Encounters Safety and Regulatory “Siege”

Mining

This Weight-Loss Drug ‘Dark Horse’ Could Take You for a Ride

Life Science

Can Palantir Justify Its 100x P/E? Mixed Signals from Institutional Investors Fuel Debate

Technology

Nvidia Stock Falls to Yearly Low, Historical Data Suggests Potential to Double

Technology

Is QuantumScape a Buy After Its 63% Plunge From Last Year’s High?

Technology

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Life Science

Lessons from History: $80 Silver May Not Be a Bargain

Mining, Precious Metals

Outpacing Inflation and Recession? These Three “Dividend Kings” Are Highly Anticipated for 2026

Consumer Goods, Financial Service, Technology

Stop Focusing Solely on Tech Stocks! Three Leading Infrastructure ETFs to Tap into America’s “Golden Decade” of Infrastructure Development

Financial Service

Will One Comment from Eli Lilly Turn Around Novo Nordisk’s Stock?

Life Science